Dermatology · Salt Lake City, UT
NPI
1477659746
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
50 N Medical Dr
Salt Lake City, UT, 84132
Phone (801) 581-2955
Groups this clinician bills Medicare through
Medicare paid, 2024
$207K
22,701 services
Medicare patients, 2024
766
Average age 75
Drug cost, 2024
$870K
2,398 prescriptions
Company payments, 2025
$99.99
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher M Hull was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 17,600 times for 58 patients. In total Christopher M Hull billed 22,701 services in 107 codes, and Medicare paid $207K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 17,600 | 58 | $1.31 | $23K |
| 17003 Destruction Skin Lesion | Office | 1,668 | 262 | $4.74 | $7,907 |
| 99213 Office E&M - Established | Office | 567 | 407 | $61.75 | $35K |
| 17003 Destruction Skin Lesion | Facility | 453 | 77 | $1.50 | $677 |
| 17000 Destruction Skin Lesion | Office | 443 | 307 | $34.54 | $15K |
| 99214 Office E&M - Established | Office | 192 | 123 | $85.30 | $16K |
| 11102 Skin Biopsy | Office | 185 | 157 | $63.67 | $12K |
| 96900 Skin | Office | 162 | 23 | $17.01 | $2,755 |
| 99213 Office E&M - Established | Facility | 128 | 105 | $46.53 | $5,955 |
| 96567 Skin | Office | 117 | 69 | $97.88 | $11K |
| 17000 Destruction Skin Lesion | Facility | 107 | 85 | $34.16 | $3,655 |
| 17110 Destruction Skin Lesion | Office | 102 | 93 | $65.98 | $6,730 |
| 36415 Venipuncture Blood Collection | Office | 78 | 52 | $8.65 | $675 |
| 85025 Blood Count | Office | 58 | 40 | $7.61 | $441 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 55 | 13 | $309.87 | $17K |
By year: 2022 $184K for 20,448 services; 2023 $213K for 25,185 services; 2024 $207K for 22,701 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 78 | 52 | $8.65 | $675 |
| 85025 Blood Count | 58 | 40 | $7.61 | $441 |
| 80053 Clinical Chemistry | 51 | 32 | $10.35 | $528 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher M Hull prescribed most often to Medicare patients was Triamcinolone Acetonide, with 182 prescriptions and refills. In total Christopher M Hull wrote 2,398 Medicare prescriptions that cost $870K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 182 | 264 | 117 | $1,701 |
| Clobetasol Propionate Generic | 158 | 176 | 86 | $6,792 |
| Hydroxychloroquine Sulfate Generic | 147 | 285 | 33 | $5,597 |
| Dapsone Generic | 126 | 206 | 24 | $9,082 |
| Mycophenolate Mofetil Generic | 117 | 195 | 29 | $9,358 |
| Ketoconazole Generic | 105 | 139 | 52 | $1,383 |
| Mupirocin Generic | 82 | 86 | 45 | $834 |
| Dexamethasone Generic | 76 | 82 | 33 | $1,773 |
| Methotrexate Methotrexate Sodium | 74 | 118 | 19 | $735 |
| Hydrocortisone Generic | 72 | 75 | 53 | $343 |
| Fluocinonide Generic | 62 | 67 | 23 | $2,123 |
| Tacrolimus Generic | 61 | 65 | 32 | $7,028 |
| Fluconazole Generic | 61 | 85 | 21 | $986 |
| Prednisone Generic | 59 | 62 | 22 | $278 |
| Azathioprine Generic | 58 | 115 | 13 | $2,659 |
Brand drugs: 181 claims; generic drugs: 2,217 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher M Hull $99.99 ($99.99 in general payments such as food, travel and fees) from 2 companies. The largest payer was Janssen Biotech, Inc. with $99.99.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $99.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.